| Literature DB >> 27853939 |
Melania Lo Iacono1,2, Rita Anzalone2,3, Giampiero La Rocca4,5, Elena Baiamonte1, Aurelio Maggio1, Santina Acuto1.
Abstract
In recent years, umbilical cord blood (UCB) has been widely used as an alternative source to bone marrow (BM) for transplantation of hematopoietic stem and progenitor cells (HSPCs) in a variety of hematological and non-hematological disorders. Nevertheless, the insufficient number of UCB-HSPCs for graft represents a major challenge. HSPCs ex vivo expansion prior to transplantation is a valid strategy to overcome this limit. Several attempts to optimize the expansion conditions have been reported, including the use of mesenchymal stromal cells (MSCs) as feeder layer. Wharton's Jelly (WJ), the main component of umbilical cord (UC) matrix, is especially rich in MSCs, which are considered ideal candidates for feeder layer in co-culture systems. In fact, they can be easily harvested and grow robustly in culture, producing a confluent monolayer in a short time. Similarly to bone marrow-mesenchymal stromal cells (BM-MSCs), WJ-derived MSCs (WJ-MSCs) have been used to support hematopoiesis in vitro and in vivo. Here, we review the rationale for using MSCs, particularly WJ-MSCs, as a feeder layer for UCB-HSPCs ex vivo expansion. In addition, we report the main findings attesting the use of these MSCs as a support in hematopoiesis.Entities:
Keywords: Bone marrow transplantation; Ex vivo expansion; Feeder layer; Hematopoietic and progenitor stem cells; Umbilical cord blood transplantation; Wharton’s jelly mesenchymal stromal cells
Mesh:
Year: 2017 PMID: 27853939 DOI: 10.1007/s12015-016-9702-4
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739